Tag: Investing

Read More

Tryptamine Therapeutics raises A$6M to advance psychedelic pipeline

Australian biotech firm Tryptamine Therapeutics Limited (ASX: TYP) secured A$6 million in new funding through a strategic placement. The placement, priced at A$0.02 per share, was backed by cornerstone investors that included Merchant Biotech Fund and biotech investor Daniel Tillett, who will join the company’s board as a non-executive director, …

Read More

Florida’s medical cannabis operators split on rollout timeline if Amendment 3 succeeds

With early voting well underway in Florida, the fate of the state’s Amendment 3, which would usher in recreational cannabis sales for adults 21 and older, is being decided. But questions linger about the measure’s timeline and how Gov. Ron DeSantis’ administration will approach what could become the nation’s third-largest …